OBJECTIVE: The objective of this study was to define a role for sphingosine-1-phosphate receptor 3 (S1PR3) in intimal hyperplasia. METHODS AND RESULTS: A denudation model of the iliac-femoral artery in wild-type and S1PR3-null mice was used to define a role for S1PR3 in the arterial injury response because we found in humans and mice that expression of S1PR3 was higher in these arteries compared with carotid arteries. At 28 days after surgery, wild-type arteries formed significantly larger lesions than S1PR3-null arteries. Bromodeoxyuridine labeling experiments demonstrated that on injury, wild-type arteries exhibited higher medial as well as intimal proliferation than S1PR3-null arteries. Because S1PR3 expression in vitro was low, we expressed S1PR3 in S1PR3-null smooth muscle cells (SMCs) using retroviral-mediated gene transfer to study the effects of S1PR3 on cell functions and signaling. SMCs expressing S1PR3, but not vector-transfected controls, responded to sphingosine-1-phosphate stimulation with activation of Rac, Erk, and Akt. SMCs expressing S1PR3 also migrated more. CONCLUSIONS: In humans and mice, S1PR3 expression was higher in iliac-femoral arteries compared with carotid arteries. S1PR3 promoted neointimal hyperplasia on denudation of iliac-femoral arteries in mice, likely by stimulating cell migration and proliferation through activation of signaling pathways involving Erk, Akt, and Rac.
OBJECTIVE: The objective of this study was to define a role for sphingosine-1-phosphate receptor 3 (S1PR3) in intimal hyperplasia. METHODS AND RESULTS: A denudation model of the iliac-femoral artery in wild-type and S1PR3-null mice was used to define a role for S1PR3 in the arterial injury response because we found in humans and mice that expression of S1PR3 was higher in these arteries compared with carotid arteries. At 28 days after surgery, wild-type arteries formed significantly larger lesions than S1PR3-null arteries. Bromodeoxyuridine labeling experiments demonstrated that on injury, wild-type arteries exhibited higher medial as well as intimal proliferation than S1PR3-null arteries. Because S1PR3 expression in vitro was low, we expressed S1PR3 in S1PR3-null smooth muscle cells (SMCs) using retroviral-mediated gene transfer to study the effects of S1PR3 on cell functions and signaling. SMCs expressing S1PR3, but not vector-transfected controls, responded to sphingosine-1-phosphate stimulation with activation of Rac, Erk, and Akt. SMCs expressing S1PR3 also migrated more. CONCLUSIONS: In humans and mice, S1PR3 expression was higher in iliac-femoral arteries compared with carotid arteries. S1PR3 promoted neointimal hyperplasia on denudation of iliac-femoral arteries in mice, likely by stimulating cell migration and proliferation through activation of signaling pathways involving Erk, Akt, and Rac.
Authors: Petra Keul; Susann Lucke; Karin von Wnuck Lipinski; Constantin Bode; Markus Gräler; Gerd Heusch; Bodo Levkau Journal: Circ Res Date: 2010-12-16 Impact factor: 17.367
Authors: M J Lee; S Thangada; J H Paik; G P Sapkota; N Ancellin; S S Chae; M Wu; M Morales-Ruiz; W C Sessa; D R Alessi; T Hla Journal: Mol Cell Date: 2001-09 Impact factor: 17.970
Authors: Y Liu; R Wada; T Yamashita; Y Mi; C X Deng; J P Hobson; H M Rosenfeldt; V E Nava; S S Chae; M J Lee; C H Liu; T Hla; S Spiegel; R L Proia Journal: J Clin Invest Date: 2000-10 Impact factor: 14.808
Authors: Robert A McDonald; Susan Pyne; Nigel J Pyne; Anne Grant; Cherry L Wainwright; Roger M Wadsworth Journal: Br J Pharmacol Date: 2009-12-15 Impact factor: 8.739
Authors: Molly E Ogle; Claire E Olingy; Anthony O Awojoodu; Anusuya Das; Rafael A Ortiz; Hoi Yin Cheung; Edward A Botchwey Journal: Stem Cells Date: 2017-01-19 Impact factor: 6.277
Authors: Jinlong Luo; Ming Liang; William E Mitch; Farhad R Danesh; Michael Yu; Jizhong Cheng Journal: Endocrinology Date: 2015-03-16 Impact factor: 4.736